Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Kotak Healthcare Reg IDCW-P
as of 22 Jul 2026, 18:54 PM
Invested Amount
Est. Return
Total Value
rated by Value Research
Your principal will be at Very High Risk
Absolute Returns
CAGR
Equity / Debt / Cash Split
Equity
98.84%
Cash
1.16%
Equity sector allocation
Basic Materials
4.92%
Healthcare
93.92%
Others
1.16%
Asset Management Company

Nippon India Taiwan Equity Reg Gr
Equity
Min. Investment
₹500
Category Returns
29.75%
63.78%
3Y Returns
+63.78%

DSP Wld Gld Mng Ovrs Eq Omni FoF Gr
Equity
Min. Investment
₹100
Category Returns
29.75%
63.78%
3Y Returns
+45.98%

DSP Wld Gld Mng Ovrs Eq Omni FoF IDCW-R
Equity
Min. Investment
₹100
Category Returns
29.75%
63.78%
3Y Returns
+45.89%
Investment Objective of the Scheme
Key Features of The Fund
5-year return
-
Fund Manager
Abhishek Bisen
Risk Profile
Very High Risk
Expense Ratio
2.45%
Fund Size
₹560.17 Cr
Kotak Healthcare Reg IDCW-P is currently priced at ₹15.35, as of 22 Jul 2026, 18:54 PM. The fund has recorded a change of ₹0.15 (0.97%), indicating its recent movement in the market.
Tracking NAV trends helps investors understand short-term price movement, while long-term performance gives a better picture of wealth creation potential.
Kotak Healthcare Reg IDCW-P is an open-ended mutual fund that invests based on its stated objective and benchmark.
Key details:
Asset Size: ₹560.17 Cr
Expense Ratio: 2.45%
Cash Holding: 1.16%
Plan Type: Growth
Benchmark: Nifty Healthcare Index PR INR
Launch Date: 2023-12-11
Exit Load: 0.50
These factors help investors evaluate cost, scale, and fund positioning before making an investment decision.
Kotak Healthcare Reg IDCW-P has delivered returns across multiple timeframes, reflecting its ability to perform across different market conditions.
Returns:
1 Month: 2.63%
3 Months: 14.26%
6 Months: 16.38%
1 Year: 17.54%
3 Years: -
5 Years: -
Short-term returns indicate recent momentum, while long-term returns show consistency and wealth creation ability.
Understanding risk is important before investing. Kotak Healthcare Reg IDCW-P falls under: For investors in the 20–40 age group, selecting a fund with the right risk level is important based on financial goals, investment horizon, and comfort with market movements.
Risk Level: Very High Risk
The riskometer helps investors understand how stable or volatile the fund can be based on its investment strategy and asset allocation. Funds with higher risk levels may offer better return potential over time, but they can also experience sharper short-term fluctuations. This classification reflects the volatility associated with the fund. Higher risk funds may offer higher returns but come with greater fluctuations.
The asset allocation of Kotak Healthcare Reg IDCW-P shows how investments are distributed across asset classes.
Equity Allocation: 98.84%
Cash Allocation: 1.16%
This allocation plays a key role in determining the fund’s risk and return profile.
Kotak Healthcare Reg IDCW-P diversifies its investments across sectors to reduce risk.
Sector Holding Detail
Basic Materials: 4.92%
Healthcare: 93.92%
Sector allocation data helps investors understand which industries the fund is focusing on.
Kotak Healthcare Reg IDCW-P is managed by:
AMC Name: Kotak Mahindra Asset Management Co Ltd
A strong fund house with a proven track record can improve investor confidence.
Investors can start investing in Kotak Healthcare Reg IDCW-P with:
Minimum Investment: ₹100
This makes the fund accessible for both beginners and experienced investors.
The Kotak Healthcare Reg IDCW-P has invested the majority of its money in the stocks of the following companies:
| Company | Percentage of Portfolio |
|---|---|
| Sun Pharmaceuticals Industries Ltd | 13.01% |
| J.B. Chemicals & Pharmaceuticals Ltd | 6.23% |
| Divi's Laboratories Ltd | 5.95% |
| Max Healthcare Institute Ltd Ordinary Shares | 5.43% |
| Cipla Ltd | 5.00% |
| Acutaas Chemicals Ltd | 4.92% |
| Fortis Healthcare Ltd | 4.31% |
| Park Medi World Ltd | 4.20% |
| Mankind Pharma Ltd | 3.18% |
| Krishna Institute of Medical Sciences Ltd | 3.12% |
| Apollo Hospitals Enterprise Ltd | 2.92% |
| Sai Life Sciences Ltd | 2.90% |
| Lupin Ltd | 2.63% |
| Anthem Biosciences Ltd | 2.44% |
| Jubilant Pharmova Ltd | 2.40% |
| Aurobindo Pharma Ltd | 2.29% |
| Marksans Pharma Ltd | 2.20% |
| Ajanta Pharma Ltd | 2.20% |
| Glenmark Pharmaceuticals Ltd | 2.03% |
| Gland Pharma Ltd | 2.01% |
| Laurus Labs Ltd | 1.95% |
| Alkem Laboratories Ltd | 1.86% |
| Rubicon Research Ltd | 1.80% |
| Orchid Pharma Ltd | 1.70% |
| Corona Remedies Ltd | 1.65% |
| Emcure Pharmaceuticals Ltd | 1.51% |
| Rainbow Childrens Medicare Ltd | 1.48% |
| Zydus Lifesciences Ltd | 1.35% |
| Yatharth Hospital and Trauma Care Services Ltd | 1.28% |
| Dr. Lal PathLabs Ltd | 1.26% |
| Laxmi Dental Ltd | 1.18% |
| Innova Captab Ltd | 1.17% |
| Metropolis Healthcare Ltd | 1.09% |
| Medi Assist Healthcare Services Ltd | 0.22% |
| Triparty Repo | 1.29% |
| Net Current Assets/(Liabilities) | 0.13% |
The Kotak Healthcare Reg IDCW-P has invested the majority of its money in the stocks of the following sectors -
| Company | Percentage of Portfolio |
|---|---|
| Basic Materials | 4.92% |
| Healthcare | 93.92% |
Investing in mutual funds is easy on HDFC SKY.
Follow these simple steps to invest in Kotak Healthcare Reg IDCW-P:
By signing up I certify terms, conditions & privacy policy